|
1 |
Intermittent theta burst stimulation of the left dorsolateral prefrontal cortex has no additional effect on the efficacy of virtual reality exposure therapy for acrophobia. A randomized double-blind placebo-controlled study
Bohmeier, Barbara. - Würzburg : Universität Würzburg, 2025
|
|
|
2 |
Treatment of Plaque Psoriasis with Guselkumab Reduces Systemic Inflammatory Burden as Measured by Neutrophil/Lymphocyte Ratio, Platelet/Lymphocyte Ratio, and Monocyte/Lymphocyte Ratio: A post hoc Analysis of Three Randomised Clinical Trials
Enthalten in Dermatology Bd. 241, 2025, Nr. 3: 272-286. 15 S.
|
|
|
|
3 |
Time to Loss of Disease Control following Guselkumab Withdrawal in Relation to Initial Speed of Response: A post hoc Analysis of the VOYAGE 2 Trial
Enthalten in Dermatology Bd. 241, 2025, Nr. 2: 133-142. 10 S.
|
|
|
|
4 |
Upadacitinib and Dupilumab Demonstrate Superior Efficacy in the Treatment of Adolescent Atopic Dermatitis: A Network Meta-Analysis
Enthalten in International archives of allergy and immunology Bd. 186, 2025, Nr. 9: 896-906. 11 S.
|
|
|
|
5 |
Advanced Biologic Therapies in the Management of Asthma in Children and Adolescents: A Comprehensive Network Meta-Analysis
Enthalten in International archives of allergy and immunology Bd. 186, 2025, Nr. 8: 733-746. 14 S.
|
|
|
|
6 |
Double-Blind, Placebo-Controlled Trial of the Efficacy and Safety of Azelastine Hydrochloride in Children with Perennial Allergic Rhinitis
Enthalten in International archives of allergy and immunology Bd. 186, 2025, Nr. 7: 670-677. 8 S.
|
|
|
|
7 |
Double-Blind, Placebo-Controlled Trial of the Efficacy and Safety of Azelastine Hydrochloride in Children with Perennial Allergic Rhinitis
Enthalten in International archives of allergy and immunology Bd. 186, 2025, Nr. 7: 670-677. 8 S.
|
|
|
|
8 |
Does Improvement of Glycemic Control Cause Acute Charcot Foot in Patients with Diabetes?
Enthalten in Experimental and clinical endocrinology & diabetes Bd. 133, 2025, Nr. 03: 120-132
|
|
|
|
9 |
Effects of a Protease Inhibitor Camostat Mesilate on Gut Microbial Function in Patients with Irritable Bowel Syndrome: A Pilot Randomized Placebo-Controlled Study
Enthalten in Digestion Bd. 106, 2025, Nr. 4: 265-276. 12 S.
|
|
|
|
10 |
Monoclonal antibodies against beta-amyloid protein (lecanemab and donanemab) should not be used in the treatment of Alzheimer's disease
Enthalten in Arquivos de neuro-psiquiatria Bd. 83, 2025, Nr. 05: 001-005
|
|
Administration
